retinol has been researched along with Bronchopulmonary Dysplasia in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (8.54) | 18.7374 |
1990's | 14 (17.07) | 18.2507 |
2000's | 16 (19.51) | 29.6817 |
2010's | 31 (37.80) | 24.3611 |
2020's | 14 (17.07) | 2.80 |
Authors | Studies |
---|---|
Nathan, EA; Patole, SK; Pillow, JJ; Rakshasbhuvankar, AA; Simmer, K | 1 |
Patole, SK; Pillow, JJ; Rakshasbhuvankar, AA; Simmer, KN | 1 |
Shen, L; Xi, W; Zhang, Z | 1 |
Ferrante, G; Giuffrè, M; Montante, C; Notarbartolo, V | 1 |
Phattraprayoon, N; Soonklang, K; Susantitaphong, P; Ungtrakul, T | 1 |
Carlo, WA; Cotten, CM; DeMauro, SB; Do, B; Jensen, EA; Laughon, MM; Watterberg, KL | 1 |
McPherson, C | 1 |
Gupta, N; Sasidharan, R; Yadav, B | 1 |
Basu, S; Khanna, P; Kumar, A; Srivastava, R | 1 |
Chandrasekaran, A; Murki, S | 1 |
Jensen, EA; Roberts, RS; Schmidt, B | 1 |
Gelfand, CA; Liu, Y; Rehan, VK; Sakurai, R; Segal, R; Wang, Y | 1 |
Clarke, MW; Nathan, EA; Patole, SK; Pillow, JJ; Rakshasbhuvankar, AA; Simmer, K; Stoecklin, B | 1 |
Chen, Z; Ding, Y; Lu, Y | 1 |
Ambalavanan, N; Bell, EF; Das, A; Greenberg, RG; Jensen, EA; Laughon, MM; Li, L; Patel, RM; Pedroza, C; Rysavy, MA; Tyson, JE | 1 |
Hu, H; Huang, X; Rong, G; Tan, C; Yu, X; Zhen, H | 1 |
Maurya, M; Siddiqui, SA | 1 |
Johnson, S; Parker, A; Schwartz, E; Zelig, R | 1 |
Chen, HJ; Chiang, BL; Hsu, CH | 1 |
Patole, S; Pillow, JJ; Rakshasbhuvankar, A; Simmer, K | 1 |
Bansal, A; Garg, BD; Kabra, NS | 1 |
Strueby, L; Thébaud, B | 1 |
Biesalski, HK; Gortner, L; Hütten, MC; Kramer, BW; Monz, D; Nikiforou, M; Nohr, D; Ophelders, D; Tschernig, T; Tutdibi, E; Wahl, HB | 1 |
Araki, S; Kato, S; Namba, F; Ota, E | 1 |
Abman, SH; Kratimenos, P; Mandell, EW; Steinhorn, RH | 1 |
Ali, Z; Dodd, J; Jeppesen, DL; Schmidt, P | 1 |
Bittner, R; Chabra, S; Gleason, CA; Mayock, DE; Neufeld, MD; Zerzan, J | 1 |
Christou, H; Ghanta, S; Leeman, KT | 1 |
Abman, SH; Cutter, GR; Gadhia, MM; Kinsella, JP | 1 |
Gortner, L; Meyer, S | 2 |
Bancalari, E; Jain, D | 1 |
Jerez-Calero, A; Miras-Baldo, M; Narbona-López, E; Uberos, J | 1 |
Boonsiri, P; Jirapradittha, J; Khampitak, T; Kiatchoosakun, P; Panthongviriyakul, MC; Yongvanit, P | 1 |
Foglia, EE; Jensen, EA; Schmidt, B | 1 |
Gawronski, CA; Gawronski, KM | 1 |
Cates, LA; Couroucli, XI; Placencia, JL; Suresh, GK | 1 |
Carlo, WA; Cotten, CM; Kennedy, KA; Watterberg, KL | 1 |
Lin, HC; Ma, L; Neu, J; Zhou, P | 1 |
Kirpalani, H; Millar, D; Roberts, R; Schmidt, B | 1 |
Greenough, A | 1 |
Askin, DF; Diehl-Jones, W | 1 |
Bose, C; Laughon, MM; Smith, PB | 1 |
Babu, TA; Sharmila, V | 1 |
Dikkeschei, BD; Kollen, BJ; Schaafsma, A; Slootstra, J; van Lingen, RA; van Zoeren-Grobben, D; Vogelsang, A | 1 |
Donovan, EF; Kaplan, HC; Margolis, PA; McClendon, D; Meinzen-Derr, J; Tabangin, ME | 1 |
Delacourt, C | 1 |
Caskey, M; Fonseca, R; Geary, C; Malloy, M; Moreira, A | 1 |
Albino-Teixeira, A; Guedes, MB; Guimarães, H; Rocha, G; Tomé, T | 1 |
Das, A; Devaskar, SU; Higgins, RD; Londhe, VA; Nolen, TL; Oh, W; Tyson, JE | 1 |
Ambalavanan, N; Carlo, WA; Kennedy, KA; Roane, C; Tyson, JE; Wu, TJ | 1 |
Albertine, KH; Bland, RD; Carlton, DP; Pierce, RA; Starcher, BC | 1 |
Cheney, C; Spears, K; Zerzan, J | 1 |
Ambalavanan, N; Carlo, WA; Hansen, NI; Kennedy, KA; Tyson, JE; Vohr, BR; Wright, LL | 1 |
Van Marter, LJ | 1 |
Cummings, J; West, T | 1 |
Groneck, P; Speer, CP | 1 |
Baveja, R; Christou, H | 1 |
Bessler, H; Osovsky, M; Prober, V; Sirota, L; Wyshelesky, G | 1 |
Chytil, F; Parker, RA; Rush, MG; Shenai, JP | 1 |
Carlson, SE; Cooke, RJ; Peeples, JM; Tolley, EA; Werkman, SH | 1 |
Gaylord, MS; Lorch, V | 1 |
Brand, JM; Pi, JT; Samuels, DP; Winston, JF; Zachman, RD | 1 |
McCulloch, KM; Verma, RP; Vidyasagar, D; Worrell, L | 1 |
Ehrenkranz, RA; Kennedy, KA; Lemons, JA; Mele, L; Oh, W; Sowell, A; Stevenson, DK; Stoll, BJ; Tyson, JE; Verter, J; Wright, LL | 1 |
Kida, K | 1 |
Chytil, F; Mellen, BG; Shenai, JP | 1 |
Atkinson, SA | 1 |
Chytil, F; Rush, MG; Shenai, JP; Stahlman, MT | 2 |
Bose, C; Bose, G; Pearson, E; Ransom, L; Snidow, T; Stiles, A; Young, T | 1 |
Hazinski, TA; Rush, MG | 1 |
Lewandoski, JR; Sharma, A; Zimmerman, JJ | 1 |
Kennedy, KA | 1 |
Georgieff, MK; Gunter, EW; Johnson, DE; Mammel, MC; Mills, MM; Thompson, TR | 1 |
Chytil, F; Gray, ME; Stahlman, MT; Sundell, H | 1 |
Chytil, F; Kennedy, KA; Shenai, JP; Stahlman, MT | 1 |
Lawson, EE; Stiles, AD | 1 |
Chytil, F; Shenai, JP; Stahlman, MT | 1 |
28 review(s) available for retinol and Bronchopulmonary Dysplasia
Article | Year |
---|---|
Vitamin A supplementation in very-preterm or very-low-birth-weight infants to prevent morbidity and mortality: a systematic review and meta-analysis of randomized trials.
Topics: Bronchopulmonary Dysplasia; Dietary Supplements; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Morbidity; Randomized Controlled Trials as Topic; Vitamin A | 2021 |
Antioxidants: Role the in prevention and treatment of bronchopulmonary dysplasia.
Topics: Antioxidants; Bronchopulmonary Dysplasia; Humans; Infant; Infant, Newborn; Infant, Premature; Oxidative Stress; Vitamin A | 2022 |
Oral vitamin A supplementation in preterm infants to improve health outcomes: A systematic review and meta-analysis.
Topics: Bronchopulmonary Dysplasia; Dexamethasone; Dietary Supplements; Humans; Infant; Infant, Newborn; Infant, Premature; Oxygen; Vitamin A | 2022 |
Contributions of the NICHD neonatal research network to the diagnosis, prevention, and treatment of bronchopulmonary dysplasia.
Topics: Adrenal Cortex Hormones; Bronchopulmonary Dysplasia; Child; Humans; Hydrocortisone; Infant; Infant, Newborn; Infant, Premature; National Institute of Child Health and Human Development (U.S.); Pulmonary Surfactants; Surface-Active Agents; United States; Vitamin A | 2022 |
Drugs to Prevent Bronchopulmonary Dysplasia: Effect of Baseline Risk on the Number Needed to Treat.
Topics: Anti-Inflammatory Agents; Bronchopulmonary Dysplasia; Caffeine; Evidence-Based Medicine; Glucocorticoids; Humans; Hydrocortisone; Infant, Newborn; Infant, Premature; Phosphodiesterase Inhibitors; Vitamin A; Vitamins | 2020 |
Vitamin A supplementation prevents the bronchopulmonary dysplasia in premature infants: A systematic review and meta-analysis.
Topics: Bronchopulmonary Dysplasia; Dietary Supplements; Female; Humans; Infant, Newborn; Infant, Premature; Male; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome, Newborn; Vitamin A | 2021 |
Vitamin A Supplementation for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants: An Update.
Topics: Birth Weight; Bronchopulmonary Dysplasia; Dietary Supplements; Humans; Infant; Infant, Premature; Infant, Premature, Diseases; Observational Studies as Topic; Vitamin A; Vitamin A Deficiency | 2017 |
Role of vitamin A supplementation in prevention of bronchopulmonary dysplasia in extremely low birth weight neonates: a systematic review of randomized trials.
Topics: Bronchopulmonary Dysplasia; Dietary Supplements; Humans; Infant; Infant Mortality; Infant, Extremely Low Birth Weight; Infant, Newborn; Randomized Controlled Trials as Topic; Vitamin A; Vitamins | 2019 |
Novel therapeutics for bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Combined Modality Therapy; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature; Mesenchymal Stem Cell Transplantation; Milk, Human; Pulmonary Surfactants; Respiratory System Agents; Vitamin A | 2018 |
Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis.
Topics: Bronchopulmonary Dysplasia; Humans; Infant, Extremely Low Birth Weight; Vitamin A | 2018 |
Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Bronchodilator Agents; Bronchopulmonary Dysplasia; Caffeine; Diuretics; Female; Humans; Infant, Newborn; Infant, Premature; Insulin-Like Growth Factor I; Mesenchymal Stem Cell Transplantation; Nitric Oxide; Oxygen Inhalation Therapy; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Pregnancy; Prenatal Care; Progesterone; Progestins; Pulmonary Surfactants; Sildenafil Citrate; Vitamin A; Vitamins | 2019 |
Bronchopulmonary dysplasia: a review.
Topics: Adrenal Cortex Hormones; Birth Weight; Bronchopulmonary Dysplasia; Caffeine; Female; Gestational Age; Humans; Hyperoxia; Infant, Newborn; Oxygen Inhalation Therapy; Phosphodiesterase Inhibitors; Pregnancy; Pulmonary Surfactants; Respiration, Artificial; Sex Factors; Vitamin A; Vitamins | 2013 |
An update on pharmacologic approaches to bronchopulmonary dysplasia.
Topics: Adrenal Cortex Hormones; Bronchodilator Agents; Bronchopulmonary Dysplasia; Diuretics; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Pulmonary Surfactants; Vitamin A; Vitamins; Xanthines | 2013 |
Bronchopulmonary dysplasia: clinical perspective.
Topics: Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Clinical Trials as Topic; Humans; Infant, Newborn; Infant, Premature; Pulmonary Alveoli; Respiration, Artificial; Steroids; Vitamin A; Vitamins | 2014 |
Evidence-Based Pharmacologic Therapies for Prevention of Bronchopulmonary Dysplasia: Application of the Grading of Recommendations Assessment, Development, and Evaluation Methodology.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchopulmonary Dysplasia; Caffeine; Cardiomyopathy, Hypertrophic; Central Nervous System Stimulants; Cerebral Palsy; Dexamethasone; Evidence-Based Medicine; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature; Intestinal Perforation; Primary Prevention; Risk Assessment; Risk Factors; Vitamin A; Vitamins | 2015 |
Vitamin A Supplementation for Prevention of Bronchopulmonary Dysplasia: Cornerstone of Care or Futile Therapy?
Topics: Bronchopulmonary Dysplasia; Diterpenes; Drug Storage; Humans; Incidence; Infant; Infant, Extremely Low Birth Weight; Infant, Newborn; Injections, Intramuscular; Respiration, Artificial; Retinyl Esters; United States; Vitamin A | 2016 |
Should we still use vitamin A to prevent bronchopulmonary dysplasia?
Topics: Bronchopulmonary Dysplasia; Cost-Benefit Analysis; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Randomized Controlled Trials as Topic; Vitamin A | 2016 |
Prevention and management of bronchopulmonary dysplasia: Lessons learned from the neonatal research network.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Benchmarking; Biomedical Research; Bronchopulmonary Dysplasia; Evidence-Based Medicine; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Neonatology; Postnatal Care; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiration, Artificial; Vitamin A | 2016 |
Potential Nutrients for Preventing or Treating Bronchopulmonary Dysplasia.
Topics: Acetylcysteine; Antioxidants; Arginine; Bronchopulmonary Dysplasia; Citrulline; Cysteine; Fatty Acids, Unsaturated; Glutamine; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Infant, Premature; Inositol; Selenium; Vitamin A; Vitamin B Complex | 2017 |
Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants.
Topics: Bronchopulmonary Dysplasia; Caffeine; Cerebral Palsy; Clinical Trials as Topic; Evidence-Based Medicine; Glucocorticoids; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Very Low Birth Weight; Injections, Intramuscular; Survival Rate; Vitamin A | 2008 |
Emerging drugs for the prevention of bronchopulmonary dysplasia.
Topics: Adrenal Cortex Hormones; Antioxidants; Bronchopulmonary Dysplasia; Humans; Infant; Infant, Newborn; Nitric Oxide; Protease Inhibitors; Vitamin A; Vitamins; Xanthines | 2008 |
Pathogenesis and prevention of chronic lung disease in the neonate.
Topics: Bronchopulmonary Dysplasia; Chorioamnionitis; Chronic Disease; Female; Humans; Incidence; Infant Nutrition Disorders; Infant, Newborn; Infant, Very Low Birth Weight; Intensive Care, Neonatal; Lung; Neonatal Nursing; Oxidative Stress; Oxygen Inhalation Therapy; Pregnancy; Pulmonary Surfactants; Respiration, Artificial; Risk Factors; Vitamin A; Vitamins | 2009 |
Strategies for preventing bronchopulmonary dysplasia.
Topics: Adrenal Cortex Hormones; Antioxidants; Bronchopulmonary Dysplasia; Continuous Positive Airway Pressure; Genetic Therapy; High-Frequency Ventilation; Humans; Hypercapnia; Infant, Newborn; Inositol; Nitric Oxide; Protease Inhibitors; Vitamin A | 2005 |
Pharmacological strategies in the prevention and management of bronchopulmonary dysplasia.
Topics: Anti-Asthmatic Agents; Antioxidants; Bronchodilator Agents; Bronchopulmonary Dysplasia; Diuretics; Humans; Infant, Newborn; Oxygen Inhalation Therapy; Protease Inhibitors; Respiratory Distress Syndrome, Newborn; Steroids; Vitamin A; Vitamins | 2006 |
[Recent advance in alveolar formation].
Topics: Animals; Bronchopulmonary Dysplasia; Cell Differentiation; Cell Division; Genes, Homeobox; Humans; Infant, Newborn; Pulmonary Alveoli; Pulmonary Emphysema; Retinoids; Vitamin A | 1998 |
Special nutritional needs of infants for prevention of and recovery from bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Calcification, Physiologic; Dexamethasone; Dietary Supplements; Fatty Acids, Nonesterified; Food, Formulated; Humans; Infant, Newborn; Infant, Premature; Inositol; Nutritional Requirements; Vitamin A; Vitamin E | 2001 |
Current therapy of bronchopulmonary dysplasia.
Topics: Adrenal Cortex Hormones; Antioxidants; Bronchodilator Agents; Bronchopulmonary Dysplasia; Clinical Trials as Topic; Diuretics; Humans; Infant, Newborn; Neonatology; Research Design; Vasodilator Agents; Vitamin A | 1992 |
Dietary antioxidants in the prevention of oxygen-induced injury.
Topics: Antioxidants; Bronchopulmonary Dysplasia; Diet; Humans; Infant, Newborn; Infant, Premature, Diseases; Oxygen Inhalation Therapy; Retinopathy of Prematurity; Vitamin A; Vitamin E | 1989 |
16 trial(s) available for retinol and Bronchopulmonary Dysplasia
Article | Year |
---|---|
Effect of Enteral Vitamin A on Fecal Calprotectin in Extremely Preterm Infants: A Nested Prospective Observational Study.
Topics: Bronchopulmonary Dysplasia; Enterocolitis, Necrotizing; Feces; Female; Humans; Infant, Extremely Premature; Infant, Newborn; Leukocyte L1 Antigen Complex; Vitamin A | 2021 |
Enteral Vitamin A for Reducing Severity of Bronchopulmonary Dysplasia: A Randomized Trial.
Topics: Administration, Oral; Bronchopulmonary Dysplasia; Double-Blind Method; Female; Humans; Infant, Extremely Premature; Infant, Newborn; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Prospective Studies; Severity of Illness Index; Treatment Outcome; Vitamin A; Vitamins | 2021 |
Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial.
Topics: Bronchopulmonary Dysplasia; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Injections, Intramuscular; Male; Respiration, Artificial; Retrospective Studies; Risk Factors; Survival Rate; United States; Vitamin A; Vitamins | 2021 |
Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.
Topics: Administration, Oral; Bronchopulmonary Dysplasia; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant, Extremely Premature; Infant, Newborn; Male; Prospective Studies; Severity of Illness Index; Treatment Outcome; Vitamin A; Vitamins | 2017 |
Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.
Topics: Administration, Inhalation; Bronchopulmonary Dysplasia; Dietary Supplements; Early Medical Intervention; Female; Humans; Incidence; Infant, Newborn; Infant, Premature; Male; Nitric Oxide; Respiratory Insufficiency; Retrospective Studies; Risk; Single-Blind Method; Vitamin A; Vitamins | 2014 |
Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
Topics: Administration, Oral; Birth Weight; Bronchopulmonary Dysplasia; Double-Blind Method; Drug Administration Schedule; Germany; Humans; Infant; Infant Mortality; Infant, Extremely Low Birth Weight; Infant, Newborn; Lung; Noninvasive Ventilation; Oxygen Inhalation Therapy; Prospective Studies; Research Design; Respiration, Artificial; Time Factors; Treatment Outcome; Vitamin A | 2014 |
Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very-low-birth-weight premature Thai infants: a randomized trial.
Topics: Bronchopulmonary Dysplasia; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Thailand; Vitamin A | 2014 |
Up-date on the NeoVitaA Trial: Obstacles, challenges, perspectives, and local experiences.
Topics: Bronchopulmonary Dysplasia; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Enteral Nutrition; Germany; Gestational Age; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Intensive Care Units, Neonatal; Vitamin A | 2017 |
Vitamin A supplementation in extremely low-birth-weight infants: subgroup analysis in small-for-gestational-age infants.
Topics: Bronchopulmonary Dysplasia; Female; Fetal Growth Retardation; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Small for Gestational Age; Male; Premature Birth; Respiration, Artificial; Vitamin A; Vitamins | 2013 |
A comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants.
Topics: Bronchopulmonary Dysplasia; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Retinol-Binding Proteins; Vitamin A | 2003 |
Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months.
Topics: Bronchopulmonary Dysplasia; Cerebral Palsy; Child Development; Developmental Disabilities; Female; Follow-Up Studies; Humans; Infant Mortality; Infant, Newborn; Infant, Very Low Birth Weight; Male; Neuropsychological Tests; Vitamin A | 2005 |
Supplementation and plasma levels of vitamin A in premature newborns at risk for chronic lung disease. Italian Collaborative Group on Preterm Delivery (ICGPD).
Topics: Bronchopulmonary Dysplasia; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Italy; Male; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Risk Factors; Vitamin A | 1993 |
Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants.
Topics: Analysis of Variance; Birth Weight; Bronchopulmonary Dysplasia; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Male; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Vitamin A; Vitamins | 1994 |
Vitamin A to prevent bronchopulmonary dysplasia in very-low-birth-weight infants: has the dose been too low? The NICHD Neonatal Research Network.
Topics: Adrenal Cortex Hormones; Bronchopulmonary Dysplasia; Drug Administration Schedule; Drug Interactions; Esters; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Meta-Analysis as Topic; Pilot Projects; Retinol-Binding Proteins; Survival Rate; Vitamin A | 1997 |
Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Diet; Double-Blind Method; Female; Humans; Incidence; Infant, Low Birth Weight; Infant, Newborn; Male; Oxygen Inhalation Therapy; Risk Factors; Treatment Outcome; Vitamin A | 1992 |
Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Clinical Trials as Topic; Disease Susceptibility; Double-Blind Method; Humans; Infant, Low Birth Weight; Infant, Newborn; Prospective Studies; Random Allocation; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Risk; Time Factors; Vitamin A | 1987 |
38 other study(ies) available for retinol and Bronchopulmonary Dysplasia
Article | Year |
---|---|
Oral vitamin A for the prevention of bronchopulmonary dysplasia in preterm infants: a meta-analysis of randomized controlled trials.
Topics: Bronchopulmonary Dysplasia; Dexamethasone; Humans; Infant; Infant, Newborn; Infant, Premature; Randomized Controlled Trials as Topic; Vitamin A | 2022 |
Pharmacotherapy for the Prevention of Bronchopulmonary Dysplasia: Can Anything Compete with Caffeine and Corticosteroids?
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Caffeine; Diuretics; Female; Humans; Infant, Premature; Macrolides; Male; Neonatal Nursing; Nitric Oxide; Practice Guidelines as Topic; Vitamin A | 2019 |
Oral vitamin A for prevention of bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Dietary Supplements; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Vitamin A | 2019 |
Oral vitamin A for prevention of mortality and bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Humans; Infant, Newborn; Infant, Premature; Vitamin A | 2019 |
Is early oral vitamin A supplementation useful in preterm neonates at risk for bronchopulmonary dysplasia?
Topics: Bronchopulmonary Dysplasia; Dietary Supplements; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Vitamin A | 2020 |
Inhaled vitamin A is more effective than intramuscular dosing in mitigating hyperoxia-induced lung injury in a neonatal rat model of bronchopulmonary dysplasia.
Topics: Acute Lung Injury; Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Hyperoxia; Lung; Pulmonary Alveoli; Pulmonary Surfactants; Rats; Vitamin A | 2020 |
VitA or VitD ameliorates bronchopulmonary dysplasia by regulating the balance between M1 and M2 macrophages.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Arginase; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Female; Humans; Infant, Newborn; Interleukin-10; Lipopolysaccharides; Macrophages; Male; Nitric Oxide Synthase Type II; Pulmonary Alveoli; Rats; Vitamin A; Vitamin D; Vitamins | 2021 |
Non-availability of Parenteral Preparations of Vitamin A: Is a Silent Surge of Bronchopulmonary Dysplasia Happening in India?
Topics: Bronchopulmonary Dysplasia; Humans; India; Infant, Newborn; Infant, Premature; Vitamin A | 2021 |
Serum retinol levels and neonatal outcomes in preterm infants.
Topics: Bronchopulmonary Dysplasia; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature; Respiratory Distress Syndrome, Newborn; Vitamin A; Vitamin A Deficiency | 2017 |
Vitamin A Supplementation by Endotracheal Application of a Nano-encapsulated Preparation Is Feasible in Ventilated Preterm Lambs.
Topics: Administration, Inhalation; Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Disease Models, Animal; Female; Gestational Age; Humans; Infant, Newborn; Infusions, Intravenous; Intubation, Intratracheal; Lung; Pregnancy; Pulmonary Surfactants; Random Allocation; Sensitivity and Specificity; Sheep; Vitamin A | 2018 |
Vitamin A status after prophylactic intramuscular vitamin A supplementation in extremely low birth weight infants.
Topics: Birth Weight; Bronchopulmonary Dysplasia; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Injections, Intramuscular; Linear Models; Male; Retinol-Binding Proteins; Retrospective Studies; Sepsis; Treatment Outcome; Vitamin A; Vitamin A Deficiency | 2013 |
Effectiveness of vitamin A in the prevention of complications of prematurity.
Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Oxygen Inhalation Therapy; Retinopathy of Prematurity; Retrospective Studies; Risk Factors; Sepsis; Vitamin A | 2014 |
Prevention of bronchopulmonary dysplasia.
Topics: Adrenal Cortex Hormones; Bronchopulmonary Dysplasia; Caffeine; Humans; Infant, Newborn; Infant, Premature; Phototherapy; Pulmonary Surfactants; Vitamin A | 2009 |
Vitamin A supplementation in late pregnancy can decrease the incidence of bronchopulmonary dysplasia in newborns.
Topics: Abnormalities, Drug-Induced; Bronchopulmonary Dysplasia; Female; Fetal Growth Retardation; Gestational Age; Humans; Immunologic Deficiency Syndromes; Infant, Low Birth Weight; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Vitamin A; Vitamin A Deficiency | 2010 |
Antioxidant role of plasma carotenoids in bronchopulmonary dysplasia in preterm infants.
Topics: alpha-Tocopherol; Antioxidants; Bronchopulmonary Dysplasia; Carotenoids; Cholesterol; Cohort Studies; Female; Humans; Infant, Newborn; Infant, Premature; Logistic Models; Male; Multivariate Analysis; Oxidative Stress; Prospective Studies; Vitamin A | 2009 |
Understanding variation in vitamin A supplementation among NICUs.
Topics: Attitude of Health Personnel; Bronchopulmonary Dysplasia; Decision Making, Organizational; Dietary Supplements; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Physician Executives; Surveys and Questionnaires; Vitamin A | 2010 |
[Vitamin A and the developing lung: long-term issues].
Topics: Bronchopulmonary Dysplasia; Diaphragmatic Eventration; Humans; Infant, Newborn; Infant, Premature; Vitamin A; Vitamin A Deficiency; Vitamins | 2011 |
Impact of providing vitamin A to the routine pulmonary care of extremely low birth weight infants.
Topics: Bronchopulmonary Dysplasia; Cohort Studies; Continuous Positive Airway Pressure; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pulmonary Surfactants; Retrospective Studies; Treatment Outcome; Vitamin A | 2012 |
Vitamin A in prevention of bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Female; Humans; Infant, Newborn; Infant, Premature; Pregnancy; Prenatal Nutritional Physiological Phenomena; Vitamin A; Vitamin A Deficiency | 2012 |
Impaired alveolar development and abnormal lung elastin in preterm lambs with chronic lung injury: potential benefits of retinol treatment.
Topics: Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Elastin; Humans; Infant, Newborn; Models, Animal; Pulmonary Alveoli; Sheep; Vitamin A | 2003 |
Low plasma retinol concentrations increase the risk of developing bronchopulmonary dysplasia and long-term respiratory disability in very-low-birth-weight infants.
Topics: Bronchopulmonary Dysplasia; Cohort Studies; Confidence Intervals; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Logistic Models; Male; Multivariate Analysis; Nutritional Status; Odds Ratio; Prognosis; Respiration, Artificial; Risk Factors; Survival Analysis; Vitamin A; Vitamin A Deficiency | 2004 |
Inadequacy of IV vitamin A supplementation of extremely preterm infants?
Topics: Bronchopulmonary Dysplasia; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Meta-Analysis as Topic; Vitamin A; Vitamin A Deficiency | 2005 |
[Pharmacological prophylaxis and treatment of bronchopulmonary dysplasia].
Topics: Adrenal Cortex Hormones; Bronchodilator Agents; Bronchopulmonary Dysplasia; Diuretics; Female; Humans; Hypertension, Pulmonary; Infant, Newborn; Lung; Pregnancy; Treatment Outcome; Vaccination; Vasodilator Agents; Vitamin A | 2005 |
A comparison of the effect of vitamin A on cytokine secretion by mononuclear cells of preterm newborns and adults.
Topics: Adult; Bronchopulmonary Dysplasia; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Fetal Blood; Humans; Infant, Newborn; Infant, Premature; Leukocytes, Mononuclear; Male; Middle Aged; Treatment Outcome; Vitamin A | 2007 |
Sequential evaluation of plasma retinol-binding protein response to vitamin A administration in very-low-birth-weight neonates.
Topics: Bronchopulmonary Dysplasia; Cohort Studies; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Prospective Studies; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Risk Factors; Vitamin A; Vitamin A Deficiency | 1995 |
Vitamin A and bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Food, Fortified; Humans; Infant, Low Birth Weight; Infant, Newborn; Parenteral Nutrition; Vitamin A | 1994 |
Use of the intramuscular relative-dose-response test to predict bronchopulmonary dysplasia in premature infants.
Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Chromatography, High Pressure Liquid; Dexamethasone; Diterpenes; Dose-Response Relationship, Drug; Gestational Age; Humans; Incidence; Infant, Newborn; Infant, Premature, Diseases; Injections, Intramuscular; Prospective Studies; Retinol-Binding Proteins; Retinyl Esters; Retrospective Studies; Vitamin A | 1996 |
Vitamin A supplementation in premature neonates with postnatal lung injury. Italian Collaborative Group on Preterm Delivery (ICGPD).
Topics: Bronchopulmonary Dysplasia; Female; Food, Fortified; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Very Low Birth Weight; Male; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Vitamin A | 1996 |
Vitamin A deficiency and severe bronchopulmonary dysplasia in very low birthweight infants.
Topics: Bronchopulmonary Dysplasia; Case-Control Studies; Enteral Nutrition; Female; Humans; Incidence; Infant, Newborn; Infant, Very Low Birth Weight; Male; Morbidity; Retrospective Studies; Vitamin A; Vitamin A Deficiency | 1996 |
Vitamin A status and postnatal dexamethasone treatment in bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Dexamethasone; Female; Glucocorticoids; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Male; Prospective Studies; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Sex Factors; Vitamin A | 2000 |
Vitamin A supplementation and bronchopulmonary dysplasia--revisited.
Topics: Bronchopulmonary Dysplasia; Humans; Infant, Low Birth Weight; Infant, Newborn; Vitamin A | 1992 |
Plasma retinol-binding protein response to vitamin A administration in infants susceptible to bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Disease Susceptibility; Enteral Nutrition; Female; Humans; Infant Nutritional Physiological Phenomena; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Injections, Intramuscular; Male; Prognosis; Prospective Studies; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Time Factors; Vitamin A | 1990 |
Retinol inhibition of in vitro human neutrophil superoxide anion release.
Topics: Adult; Bronchopulmonary Dysplasia; Humans; In Vitro Techniques; Infant, Newborn; Inflammation; Neutrophils; Superoxides; Vitamin A; Vitamin A Deficiency | 1990 |
Effect of postnatal steroid administration on serum vitamin A concentrations in newborn infants with respiratory compromise.
Topics: Bronchopulmonary Dysplasia; Dexamethasone; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Nutritional Status; Prealbumin; Prospective Studies; Retinol-Binding Proteins; Vitamin A | 1989 |
Effect of retinol on fetal lamb tracheal epithelium, with and without epidermal growth factor. A model for the effect of retinol on the healing lung of human premature infants.
Topics: Analysis of Variance; Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Cell Differentiation; Cell Division; Disease Models, Animal; Epidermal Growth Factor; Epithelium; Female; Fetus; Humans; Infant, Newborn; Metaplasia; Microscopy, Electron; Pregnancy; Sheep; Trachea; Vitamin A; Vitamin A Deficiency | 1988 |
Vitamin A therapy for prevention of chronic lung disease in infants.
Topics: Bronchopulmonary Dysplasia; Chronic Disease; Humans; Infant; Infant, Newborn; Infant, Premature; Vitamin A | 1987 |
Low plasma vitamin A levels in preterm neonates with bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Vitamin A | 1986 |
Vitamin A status of neonates with bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Female; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infant, Premature; Male; Vitamin A; Vitamin A Deficiency | 1985 |